Posted: 1 Mar 2014
Date Written: 2013
Novel nanomedical interventions require human testing to evaluate their safety and effectiveness. To establish a proper evidentiary basis for human trials, nanomedical innovations must first be subjected to animal and other laboratory testing. But it is uncertain whether the traditional laboratory approaches to safety evaluation will supply adequate information on nanotechnology risks to humans. This uncertainty, together with other features of nanomedical innovation, heightens the ethical challenges in conducting first-in-human nanotrials.
Suggested Citation: Suggested Citation
Dresser, Rebecca, Building an Ethical Foundation for First-in-Human Nanotrials (2013). Journal of Law, Medicine and Ethics, Vol. 40, No. 4, 2013; Washington University in St. Louis Legal Studies Research Paper No. 14-02-08. Available at SSRN: https://ssrn.com/abstract=2401950